CLINICAL TRIALS PROFILE FOR BREVICON 21-DAY
✉ Email this page to a colleague
All Clinical Trials for BREVICON 21-DAY
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00504816 ↗ | A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers | Completed | GlaxoSmithKline | Phase 1 | 2007-04-01 | The purpose of this research study is to demonstrate a lack of effect of multiple doses of GSK189075 on the PK of an oral contraceptive pill in healthy female subjects. To estimate the effects of GSK189075 on hormonal levels and on birth control. |
| NCT01077505 ↗ | An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide . | Completed | GlaxoSmithKline | Phase 1 | 2010-03-15 | This study will be an open-label study to evaluate the effect of albiglutide on the pharmacokinetics and pharmacodynamics of a standard oral contraceptive regimen (Brevicon). The primary objective of this study is to demonstrate the lack of effect of albiglutide doses on the pharmacokinetics of norethindrone and ethinyl estradiol in healthy female subjects. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BREVICON 21-DAY
Condition Name
Clinical Trial Locations for BREVICON 21-DAY
Trials by Country
Clinical Trial Progress for BREVICON 21-DAY
Clinical Trial Phase
Clinical Trial Sponsors for BREVICON 21-DAY
Sponsor Name
